Research Ethics

The MUHC Research Ethics Board (REB) is the evaluating body for ethical and scientific review at this institution.

The MUHC REB reviews all research involving humans under its auspice, to help ensure it meets the required ethical and scientific standards.

  • There is one MUHC REB and 5 specialised panels
  • The 5 specialised panels will conduct both Science and Ethics review and will meet twice a month on average;
  • Submission deadlines are abolished;

The CAE staff will conduct pre-reviews of all studies to ensure 

  • completeness, 
  • minimal quality of documents submitted and 
  • assess level of risk and initiate delegated review of minimal risk studies (instead of full board reviews).

The MUHC currently has a single REB with 5 specialized panels :

  • PED
  • NEUPSY
  • CT1 (Oncology)
  • CT2
  • CTGQ

5 Panels of the MUHC-REB

Pediatrics (PED):

  • All projects involving minors

Clinical Trials 1 (CT1):

  • Oncology
  • Radiation-oncology
  • ObGyn
  • Urology
  • Palliative care research associated to oncology

Cells, tissues, genetics & qualitative research (CTGQ):

  • Artificial intelligence (AI)
  • Genetics
  • Biobanking and registries
  • Research on cells and tissues
  • Experimental  cell therapies
  • Pathology
  • Regenerative medicine
  • Epidemiology 
  • Qualitative research
  • Fundamental research

Neurosciences-Psychiatry (NEUPSY):
All projects in:

  • Neuroscience
  • Psychiatry
  • Psychology

Clinical Trials 2 (CT2):

  • Surgery
  • Cardiology
  • Orthopaedics
  • Endocrinology
  • Anesthesiology
  • Gastroenterology
  • Urology
  • Devices
  • Infectious diseases
  • Chronic illness
  • Respiratory and
  • Transplant

Schedule of REB FULL BOARD meetings

For the schedule of REB full board meetings, please see the calendar page on Nagano. Note that studies that are more than minimal risk are reviewed by the full board.

Please enter your study in Nagano as soon as possible to initiate the review process.

Delegated Reviews

Delegated reviews are conducted on an ongoing basis for minimal risk studies.
 

MUHC REB Chair:  Marie Hirtle

PanelsCo-Chairs:REB Coordination 
PEDSDr. Carlo CiceroMs. Elizabeth Craven
NEUPSYDr. Serge Gauthier, Dr. Simon DucharmeMs. Bonnie McKeating
CT1Mr. Vincent LajoieMs. Elizabeth Craven
CT2 Ms. Sonya Page, Ms. Franca Cantini, Dr. Alan SnidermanMs. Sonia Cantini, Ms. Farah Youssef
CTGQMe Marie HirtleMr. James Ellasus

Other REB Co-Chairs: Me Brigitte Paquet, Mr. Renaud Boulanger

Other REB Coordinator: Ms Joanne Lebrasseur

For panel contact information click here.

Updated February 6, 2025